Edgewise Therapeutics's common stock is $10K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
Edgewise Therapeutics (EWTX) currently reports a common stock of $10K as of June 2026. That compares with $10K in the prior-year period — up 0.0% year over year. Use the charts on this page to explore Edgewise Therapeutics's common stock history and peer comparisons.
Edgewise Therapeutics's common stock was unchanged from $10K to $10K — essentially flat versus a year earlier (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Edgewise Therapeutics reported $10K in common stock as of June 2026. That compares with $10K in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $10K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Edgewise Therapeutics, and consider following EWTX for alerts when major investors trade the stock.
Edgewise Therapeutics is classified in the Healthcare sector. On common stock, it currently shows $10K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EWTX with unrelated industries.